Medibank Private Limited (ASX:MPL – Get Free Report) insider David Koczkar purchased 457,907 shares of the firm’s stock in a transaction on Monday, September 2nd. The shares were acquired at an average cost of A$3.99 ($2.71) per share, with a total value of A$1,827,048.93 ($1,242,890.43).
Medibank Private Stock Performance
The company has a debt-to-equity ratio of 9.47, a quick ratio of 1.50 and a current ratio of 1.89.
Medibank Private Increases Dividend
The business also recently disclosed a Final dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 25th will be issued a dividend of $0.094 per share. The ex-dividend date is Tuesday, September 3rd. This represents a yield of 2.37%. This is a boost from Medibank Private’s previous Final dividend of $0.08. Medibank Private’s dividend payout ratio (DPR) is presently 94.44%.
Medibank Private Company Profile
Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy.
Recommended Stories
- Five stocks we like better than Medibank Private
- What is MarketRank™? How to Use it
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
- What is a Dividend King?
- Casey’s General Stores: The Dividend Growth Stock You Can’t Miss
Receive News & Ratings for Medibank Private Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medibank Private and related companies with MarketBeat.com's FREE daily email newsletter.